Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Nonrecurring Basis Measurements (Details)

v3.24.4
Fair Value of Financial Instruments - Nonrecurring Basis Measurements (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Nov. 30, 2024
Nov. 30, 2023
Nov. 30, 2024
Nov. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Goodwill impairment, total losses $ 0.0 $ 0.0 $ 2,250.0 $ 0.0
Equity method investments, total losses 0.3 0.3 2.4 136.1
Nonrecurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Goodwill impairment, total losses     2,250.0  
Equity method investments, total losses     2.4 136.1
Asset impairment charges     2,252.4  
Nonrecurring | Quoted Prices in Active Markets (Level 1)        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Goodwill 0.0   0.0  
Equity method investments 0.0 94.8 0.0 94.8
Assets at fair value 0.0   0.0  
Nonrecurring | Significant Other Observable Inputs (Level 2)        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Goodwill 0.0   0.0  
Equity method investments 0.0 0.6 0.0 0.6
Assets at fair value 0.0   0.0  
Nonrecurring | Significant Unobservable Inputs (Level 3)        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Goodwill 491.3   491.3  
Equity method investments 0.0 $ 0.6 0.0 $ 0.6
Assets at fair value $ 491.3   $ 491.3